LeMaitre Vascular

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LMAT and other ETFs, options, and stocks.

About LMAT

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. 

CEO
George W. LeMaitre
CEOGeorge W. LeMaitre
Employees
655
Employees655
Headquarters
Burlington, Massachusetts
HeadquartersBurlington, Massachusetts
Founded
1983
Founded1983
Employees
655
Employees655

LMAT Key Statistics

Market cap
2.42B
Market cap2.42B
Price-Earnings ratio
42.26
Price-Earnings ratio42.26
Dividend yield
0.75%
Dividend yield0.75%
Average volume
347.13K
Average volume347.13K
High today
$106.75
High today$106.75
Low today
$104.47
Low today$104.47
Open price
$105.67
Open price$105.67
Volume
171.23K
Volume171.23K
52 Week high
$115.33
52 Week high$115.33
52 Week low
$71.42
52 Week low$71.42

Stock Snapshot

LeMaitre Vascular(LMAT) stock is priced at $106.15, giving the company a market capitalization of 2.42B. It carries a P/E multiple of 42.26 and pays a dividend yield of 75.2%.

During the trading session on 2026-03-05, LeMaitre Vascular(LMAT) shares reached a daily high of $106.75 and a low of $104.47. At a current price of $106.15, the stock is +1.6% higher than the low and still -0.6% under the high.

Trading volume for LeMaitre Vascular(LMAT) stock has reached 171.23K, versus its average volume of 347.13K.

Over the past 52 weeks, LeMaitre Vascular(LMAT) stock has traded between a high of $115.33 and a low of $71.42.

Over the past 52 weeks, LeMaitre Vascular(LMAT) stock has traded between a high of $115.33 and a low of $71.42.

LMAT News

Simply Wall St 3d
LeMaitre Vascular Is Up 16.4% After Strong Earnings, Dividend Hike And New Buyback Plan – Has The Bull Case Changed?

In late February 2026, LeMaitre Vascular reported strong fourth-quarter and full-year 2025 results, issued upbeat 2026 guidance, raised its quarterly dividend t...

LeMaitre Vascular Is Up 16.4% After Strong Earnings, Dividend Hike And New Buyback Plan – Has The Bull Case Changed?
Nasdaq 7d
LMAT Crosses Above Average Analyst Target

In recent trading, shares of LeMaitre Vascular Inc (Symbol: LMAT) have crossed above the average analyst 12-month target price of $51.75, changing hands for $51...

LMAT Crosses Above Average Analyst Target

Analyst ratings

67%

of 9 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

People also own

Based on the portfolios of people who own LMAT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.